BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
3.45
↓ 83% below average
Average (9y)
19.88
Historical baseline
Range
High:69.96
Low:3.45
CAGR
-15.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.45 | -0.7% |
| 2023 | 3.47 | -55.9% |
| 2022 | 7.88 | -50.1% |
| 2021 | 15.78 | -77.4% |
| 2020 | 69.96 | +756.7% |
| 2019 | 8.17 | -79.7% |
| 2018 | 40.32 | +144.9% |
| 2017 | 16.46 | -7.0% |
| 2016 | 17.70 | +13.5% |
| 2015 | 15.59 | - |